133 related articles for article (PubMed ID: 30793490)
1. Wuzhi capsule regulates chloroacetaldehyde pharmacokinetics behaviour and alleviates high-dose cyclophosphamide-induced nephrotoxicity and neurotoxicity in rats.
Chen L; Xiong X; Hou X; Wei H; Zhai J; Xia T; Gong X; Gao S; Feng G; Tao X; Zhang F; Chen W
Basic Clin Pharmacol Toxicol; 2019 Aug; 125(2):142-151. PubMed ID: 30793490
[TBL] [Abstract][Full Text] [Related]
2. Schisandra chinensis extract decreases chloroacetaldehyde production in rats and attenuates cyclophosphamide toxicity in liver, kidney and brain.
Zhai J; Zhang F; Gao S; Chen L; Feng G; Yin J; Chen W
J Ethnopharmacol; 2018 Jan; 210():223-231. PubMed ID: 28821392
[TBL] [Abstract][Full Text] [Related]
3. Effects of traditional chinese medicine Wuzhi capsule on pharmacokinetics of tacrolimus in rats.
Wei H; Tao X; Di P; Yang Y; Li J; Qian X; Feng J; Chen W
Drug Metab Dispos; 2013 Jul; 41(7):1398-403. PubMed ID: 23628674
[TBL] [Abstract][Full Text] [Related]
4. The Influence of Wuzhi Capsule on the Pharmacokinetics of Cyclophosphamide.
Chen L; Ji N; Zhang M; Chen W
Recent Pat Anticancer Drug Discov; 2022; 17(2):195-203. PubMed ID: 34758719
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy.
Kurowski V; Wagner T
Cancer Chemother Pharmacol; 1993; 33(1):36-42. PubMed ID: 8269587
[TBL] [Abstract][Full Text] [Related]
6. Effect of hepar-protecting Wuzhi capsule on pharmacokinetics and dose-effect character of tacrolimus in healthy volunteers.
Teng F; Wang W; Zhang W; Qu J; Liu B; Chen J; Liu S; Li M; Chen W; Wei H
Biopharm Drug Dispos; 2022 Aug; 43(4):119-129. PubMed ID: 35180322
[TBL] [Abstract][Full Text] [Related]
7. Exploring the effect of Wuzhi capsule on the pharmacokinetics of regorafenib and its main metabolites in rat plasma using liquid chromatography-tandem mass spectrometry.
Zhu J; Zhong L; Song Y; Ding H; Xin W; Xu G; Fang L
J Sep Sci; 2024 Mar; 47(5):e2300923. PubMed ID: 38466147
[TBL] [Abstract][Full Text] [Related]
8. Time- and NADPH-Dependent Inhibition on CYP3A by Gomisin A and the Pharmacokinetic Interactions between Gomisin A and Cyclophosphamide in Rats.
Zhai J; Zhang F; Gao S; Chen L; Feng G; Yin J; Chen W
Molecules; 2017 Aug; 22(8):. PubMed ID: 28786954
[TBL] [Abstract][Full Text] [Related]
9. Novel insights into the mechanism of cyclophosphamide-induced bladder toxicity: chloroacetaldehyde's contribution to urothelial dysfunction in vitro.
Mills KA; Chess-Williams R; McDermott C
Arch Toxicol; 2019 Nov; 93(11):3291-3303. PubMed ID: 31598736
[TBL] [Abstract][Full Text] [Related]
10. Wuzhi capsule increased systemic exposure to methotrexate by inhibiting the expression of OAT1/3 and P-gp.
Fu R; Wang XN; Guo CH; Li Y; Ding CY; Li YJ; Dong ZJ
Ann Transl Med; 2021 May; 9(10):845. PubMed ID: 34164479
[TBL] [Abstract][Full Text] [Related]
11. The effects of oral glutamine on cyclophosphamide-induced nephrotoxicity in rats.
Abraham P; Isaac B
Hum Exp Toxicol; 2011 Jul; 30(7):616-23. PubMed ID: 20621952
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of cyclosporine-induced renal dysfunction by catechin: possible antioxidant mechanism.
Anjaneyulu M; Tirkey N; Chopra K
Ren Fail; 2003 Sep; 25(5):691-707. PubMed ID: 14575278
[TBL] [Abstract][Full Text] [Related]
13. Curcumin alleviates colistin-induced nephrotoxicity and neurotoxicity in rats via attenuation of oxidative stress, inflammation and apoptosis.
Edrees NE; Galal AAA; Abdel Monaem AR; Beheiry RR; Metwally MMM
Chem Biol Interact; 2018 Oct; 294():56-64. PubMed ID: 30138604
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of safranal to cisplatin-induced nephrotoxicity.
Karafakıoğlu YS; Bozkurt MF; Hazman Ö; Fıdan AF
Biochem J; 2017 Mar; 474(7):1195-1203. PubMed ID: 28188255
[TBL] [Abstract][Full Text] [Related]
15. Ifosfamide metabolite chloroacetaldehyde causes renal dysfunction in vivo.
Springate JE
J Appl Toxicol; 1997; 17(1):75-9. PubMed ID: 9048231
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetic study of tacrolimus and
Qu J; Bian R; Liu B; Chen J; Zhai J; Teng F; Guo W; Wei H
Front Pharmacol; 2022; 13():956166. PubMed ID: 36188616
[No Abstract] [Full Text] [Related]
17. Nitrosative stress, protein tyrosine nitration, PARP activation and NAD depletion in the kidneys of rats after single dose of cyclophosphamide.
Abraham P; Rabi S
Clin Exp Nephrol; 2009 Aug; 13(4):281-287. PubMed ID: 19266253
[TBL] [Abstract][Full Text] [Related]
18. Effects of ketoconazole on cyclophosphamide metabolism: evaluation of CYP3A4 inhibition effect using the in vitro and in vivo models.
Yang L; Yan C; Zhang F; Jiang B; Gao S; Liang Y; Huang L; Chen W
Exp Anim; 2018 Feb; 67(1):71-82. PubMed ID: 29129847
[TBL] [Abstract][Full Text] [Related]
19. Effects of low dose pre-irradiation on hepatic damage and genetic material damage caused by cyclophosphamide.
Yu HS; Song AQ; Liu N; Wang H
Eur Rev Med Pharmacol Sci; 2014; 18(24):3889-97. PubMed ID: 25555880
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of cisplatin-induced nephrotoxicity in rats by tetramethylpyrazine, a major constituent of the Chinese herb Ligusticum wallichi.
Ali BH; Al-Moundhri M; Eldin MT; Nemmar A; Al-Siyabi S; Annamalai K
Exp Biol Med (Maywood); 2008 Jul; 233(7):891-6. PubMed ID: 18445776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
